AnaptysBio (LTS:0HFQ) Purchase Of Investment : $-443.9 Mil (TTM As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is AnaptysBio Purchase Of Investment?

AnaptysBio's purchase of investment for the three months ended in Mar. 2025 was $-122.5 Mil. It means AnaptysBio spent $122.5 Mil on purchasing investments. AnaptysBio's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2025 was $-443.9 Mil.

Compared with last quarter ($-120.9 Mil in Dec. 2024 ), AnaptysBio spent more money on purchasing investments in Mar. 2025 ($-122.5 Mil).

AnaptysBio Purchase Of Investment Historical Data

The historical data trend for AnaptysBio's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AnaptysBio Purchase Of Investment Chart

AnaptysBio Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Purchase Of Investment

Get a 7-Day Free Trial

-194.93

-118.66

-802.50

-303.92

-380.38

AnaptysBio Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Purchase Of Investment	Get a 7-Day Free Trial															-59.00	-149.15	-51.35	-120.88	-122.55

AnaptysBio Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-443.9 Mil.

AnaptysBio Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of AnaptysBio's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

AnaptysBio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AnaptysBio Inc (LTS:0HFQ) » Definitions » Purchase Of Investment

Comparable Companies

Traded in Other Exchanges

ANAB:USA AN6:Germany

Address

10770 Wateridge Circle, Suite 210, San Diego, CA, USA, 92121

Website

https://www.anaptysbio.com

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

AnaptysBio Headlines

No Headlines